Observation Of The Clinical Efficacy Of "Stroke Integration" In The Treatment Of Ischemic Stroke (stroke)

Objective:1.Review and observe the clinical efficacy of "stroke integration" in the treatment of stroke.2.Promote the "integration of stroke" treatment of stroke disease.Method:This study collected the "stroke" medical records of the Xiyuan Hospital's encephalopathy from January to March 2015 and the "stroke integration" treatment from January to March 2018.The TCM syndrome types are "Zero syndrome group","Evidence group" and "Virtual and real syndrome group".Through the NIHSS score,the relationship between the change of the B1 index and the TCM syndrome is observed.Result:Among the inpatients in the encephalopathy department of Xiyuan Hospital from Ja nuary to March 2015,85 patients were diagnosed with ischemic stroke(stroke),and 89 patients were from January to March 2018.Among them,the NIHSS score of 1 or more and the Bl index score of 95 or less were 51 cases in 2015 and 61 cases in 2018.A total of 112 cases were collected.In 2015.the male to female ratio was 31 males and 20 females;in 2018,36 males and 25 females.The average age of patient s in 2015 was 67.90 years;in 2018.it was 69.44 years.The average hospitalization d ate in 2015 was 18.45 days;the average hospitalization days in 2018 was 13.62 days.Before 2015,the average NIHSS score was 4.71 points after treatment,and the aver age score was 3.27 points after treatment.The average B1 index before treatment was 54.9 points,and the average score after treatment was 65.1 points.The average NIH SS score before treatment in 2018 was 5.02 points.The average was 3.38 points;the average B1 index before treatment was 60.00 points,and the average after treatment was 72.62 points;the difference between before and after treatment in 2015 and 2018 was statistically significant(P<0.05).Contrast effects were measured in 2015 and 2018,and the effect in 2018 was significantly better than in 2015.According to the NIHSS score,the average NIHSS score before treatment in the de ficiency group in 2015 was 3.94 points,and 3.22 points after treatment.The average NIHSS score before treatment in the 2018 deficiency group was 6.8 points,and 5.8 p oints after treatment.The mean NIHSS score before treatment in the empirical group i n 2015 was 5.07 points,and 3.17 points after treatment;the average NIHSS score bef ore the treatment In the 2018 group was 4.52 points,and 2.55 points after treatment.In 2015,the average NIHSS score before treatment was 5.67 points and 4.67 points a fter treatment.In the 2018,the average NIHSS score before treatment was 4.23 points and 2.54 points after treatment.The difference between the treatment groups before a nd after treatment was P<0.05,which was tatistically significant.Among them,in 2015 and 2018,the improvement of the NIHSS score of the empirical group was better than that of the deficiency group and the virtual and real syndroime group.According to the B1 index,the pre-treatment B1 index score of the deficiency group in 2015 was 55 points and 63.89 points after treatment.In the 2018 deficiency grou p,the pre-treatment B1 index score was 63 points on average and 72.33 points after t reatment.In 2015,the average index of the B1 index before treatment in the empirical group was 55.33 points,and 66.5 points after treatment;in the 2018 group,the aver age index of the Bl index before treatment was 58.48 points,and after treatment,it w as 72.27 points.In 2015,the B index of the pre-treatment group was 50 points and 58.33 points after treatment.In the 2018,the B-index before treatment was 60,38 point s an d 73.8;5 points after treatment.The difference be tween the treatment groups before and after treatment was P<0.05,which was statistically significant.Among them,in 2015 and 2018,the improvement of the empirical index B1 index was better than that of the deficiency syndrome group and the virtual and real inclusion syndrome group.Through the changes in the efficacy of NIHSS and B1 index before and after treat ment in 2015 and 2018,the NIHSS score of the deficient group in 2015 was 0.72 po ints lower than that before treatment.and the B1 index was increased by 8.89 points.The NIHSS score of the 2018 deficiency group was compared with that before treatm ent.Decrease by 1 point;the B1 index increases by 9.33 points.In 2015,the NIHSS of the empirical group decreased by 1.9 points before the treatment,and the B1 index score increased by 11.17 points;the NIHSS of the empirical group in 2018 decrease d by 1.97 points before the treatment;the index of the B1 index increased by 13.79 p oints.In 2015,the NIHSS of the virtual and real group decreased by 1 point and the B1 index score increased by 8.33 points.In 2018.the NIHSS of the virtual and real group decreased by 1.69 points and the B1 index score increased by 13.47 points.It can be seen that the improvement of the NIHSS score and the B1 index in 2018 is significantly better than that in 2015.The improvement of NI-HSS score and B1 in dex of the deficiency group in 2018 is better than that of 2015;the improvement of NIHSS score and B1 index of the empirical group in 2018 is better than that of 2015;the improvement of NIHSS score and B1 index of the virtual and organic syndrome group in 2018 In 2015.